Innovation networks in the biopharmaceutical sector: a study of UK small- and medium-sized enterprises
by Calin Gurau
International Journal of Entrepreneurship and Innovation Management (IJEIM), Vol. 5, No. 1/2, 2005

Abstract: Innovation is considered one of the most important strategic and competitive elements of a successful biopharmaceutical firm. The small- and medium-sized firms need to participate in innovation networks in order to attract or outsource the necessary resources for the successful development of new projects. The complexity of the product development cycle forces the firm to participate in multiple networks, fulfilling various roles. This study investigates the structure and the dynamics of innovation networks in the UK biopharmaceutical sector, analysing the networking approach and the roles adopted by biopharmaceutical SMEs.

Online publication date: Tue, 22-Feb-2005

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Entrepreneurship and Innovation Management (IJEIM):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com